Dss, Inc. (DSS) Stock Price & Analysis
Dss, Inc. (DSS) fell 2.14% to USD 0.55 as of July 25, 2026 at 03:04 UTC, according to Nexqual real-time market data.
DSS last closed at USD 0.56; the session ranged USD 0.54–0.58 on volume of 24,546 shares. Market capitalization is —, with a 52-week range of USD 0.36–1.9 (ASE). Source: Nexqual, July 25, 2026 at 03:04 UTC.
Key Statistics (as of July 25, 2026 at 03:04 UTC)
| Price | USD 0.55 |
|---|---|
| Change | ▼ 2.14% (down) |
| Previous Close | USD 0.56 |
| Open | USD 0.55 |
| Day Range | USD 0.54 – 0.58 |
| 52-Week Range | USD 0.36 – 1.9 |
| Volume | 24,546 shares |
| Market Cap | — |
| Exchange | ASE |
Technical Analysis (DSS)
Nexqual's technical model rates DSS "SELL" based on 2 bullish and 4 bearish signals across 125 daily candles, as of July 25, 2026 at 03:04 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 47.72 (neutral) |
| vs SMA50 | Below (USD 0.56) |
| MACD | 0 (positive) |
Analyst Ratings (DSS)
Wall Street analysts rate DSS "None", per Nexqual as of July 25, 2026 at 03:04 UTC.
| Consensus Rating | None |
|---|
Earnings (DSS)
Source: Nexqual, July 25, 2026 at 03:04 UTC.
Financials & Fundamentals (DSS)
| Total Revenue | $20.13M |
|---|---|
| Revenue Growth (YoY) | -12.60% |
| Gross Margin | -15.59% |
| Operating Margin | -126.69% |
| Profit Margin | -124.02% |
| ROE | -134.76% |
| Debt / Equity | 345.74 |
| Current Ratio | 0.22 |
| Total Cash | $5.92M |
| Total Debt | $43.37M |
| Free Cash Flow | $40.54M |
Source: Nexqual, July 25, 2026 at 03:04 UTC.
Financial Health Score (DSS)
Nexqual rates Dss, Inc.'s overall financial health "Weak" across five dimensions, as of July 25, 2026 at 03:04 UTC.
| Growth | Critical — Revenue -13% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Critical — $6M cash vs $43M debt |
| Cash Flow | Strong — FCF $41M, 201% margin |
| Efficiency | Critical — ROE -135%, ROA -12.4% |
Ownership (DSS)
| Insider Ownership | +108.67% |
|---|---|
| Institutional Ownership | +2.24% |
| Float | 4.02M |
| Short % of Float | +11.92% |
Source: Nexqual, July 25, 2026 at 03:04 UTC.
Leadership (DSS)
Dss, Inc. is led by Jason T. Grady (age 51), Interim Chief Executive Officer, per Nexqual as of July 25, 2026 at 03:04 UTC.
| Interim Chief Executive Officer | Jason T. Grady (age 51) |
|---|---|
| Executive Chairman of the Board | Heng Fai Chan (age 80) |
| President & Director | Tung Moe Chan BApSc, MBA, MEng (age 46) |
| Chief Financial Officer | Todd D. Macko (age 52) |
Major Backers & Investors (DSS)
Notable institutional backers of Dss, Inc. include Fidelity, Renaissance Technologies, Citadel, according to Nexqual as of July 25, 2026 at 03:04 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 0.52% |
| Renaissance Technologies | 0.37% |
| Citadel | 0.19% |
| Susquehanna International Group, LLP | 0.12% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.23% |
| Geode Capital | 0.54% |
| BlackRock | 0.21% |
Source: Nexqual, July 25, 2026 at 03:04 UTC.
From Dss, Inc.'s Latest SEC 10-K Filing (filed 2026-03-31)
Key Strengths & Strategy (as disclosed to the SEC)
- This provider brings additional layers of security through services including:         Our approach to cybersecurity is proactive and multifaceted, combining the scalability and reliability of the Microsoft cloud services with the agility and expertise of our third-party cybersecurity partner.
- As part of this commitment, we leverage a sophisticated cybersecurity framework that integrates the robust capabilities of the Microsoft cloud ecosystem with the specialized services of a leading third-party cybersecurity service provider.   The Microsoft cloud ecosystem, including Microsoft 365, Azure, SharePoint Online, Microsoft Defender, and Microsoft InTune, forms the backbone of our cybersecurity infrastructure.
- If we become involved in litigation, we could lose our proprietary rights, be subject to damages and incur substantial unexpected operating expenses.
- We aim to take our businesses public once they reach an optimal point for effective leverage and meet internal goals and expectations.   Decentralized Sharing Model: We firmly believe in our unique decentralized sharing model, combined with the three-stage development process, to create substantial shareholder value.
Partnerships
- The Company disclosed that a portion of the proceeds was used to reduce outstanding debt.   June 24, 2025 – DSS, Inc.'s subsidiary, Impact BioMedical Inc., announced that it entered into a definitive merger agreement with Dr.
- The Securities and Investment Management segment remains a key pillar of our growth strategy, with expanding initiatives that include real estate investment, digital securities, and wealth management solutions.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| VISL | Vislink Technologies, Inc. | USD 2.82 | ▼ 2.42% |
| BOXL | Boxlight Corporation | USD 3.55 | ▲ 3.5% |
| ITRMF | Iterum Therapeutics plc | USD 0.03 | ▲ 0% |
| IZEA | IZEA Worldwide, Inc. | USD 3.4 | ▲ 0% |
| OGEN | Oragenics Inc. | USD 0.51 | ▼ 3.58% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:04 UTC. This page is informational and not investment advice.